Activated charcoal microcapsules and their applications

被引：24

作者：

Chandy, T ^{[1
]}

Sharma, CP ^{[1
]}

机构：

[1] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Biosurface Technol, Trivandrum 695012, Kerala, India

来源：

JOURNAL OF BIOMATERIALS APPLICATIONS | 1998年 / 13卷 / 02期

关键词：

activated charcoal; microencapsulation; hemoperfusion; chitosan encapsulated charcoal; adsorbent for toxins; blood compatibility;

D O I：

10.1177/088532829801300204

中图分类号：

R318 [生物医学工程];

学科分类号：

0831 [生物医学工程];

摘要：

Activated charcoal, long known to the ancients as a substance of therapeutic value in a variety of maladies, has recently been "rediscovered" to be of great value in medical applications. Activated charcoal hemoperfusion is effective in blood purification for removal of various circulating toxic materials and waste metabolites, directly. However, particulate release and platelet adhesion prevent its continued clinical use. Polymeric coatings or microencapsulation of charcoal within polymers have improved their blood compatibility. Chitosan encapsulated activated charcoal (ACCB) beads have been extensively investigated in our group for the removal of various toxins such as urea, creatinine, uric acid, bilirubin, etc. This article highlights various methods of microencapsulation procedures of activated charcoal and the importance of this novel material for a variety of biomedical applications. Further, this review provides an insight to the future perspectives for using them in clinical practice.

引用

页码：128 / 157

页数：30

共 79 条

[1]

ANDRADE JD, 1972, T AM SOC ART INT ORG, V18, P473

[2]

ASH SR, 1992, INT J ARTIF ORGANS, V15, P151

[3]

Beena M S, 1994, J Biomater Appl, V8, P385, DOI 10.1177/088532829400800405

[4]

INVITRO INVESTIGATIONS WITH SELECTIVE ADSORBENTS FOR IGE AND IGM [J].

BEHM, E ;

KURODA, T ;

YAMAWAKI, N ;

TSUDA, N ;

LOTH, F ;

SCHWACHULA, G ;

SABROWSKI, E ;

FALKENHAGEN, D ;

KLINKMANN, H .

BIOMATERIALS ARTIFICIAL CELLS AND ARTIFICIAL ORGANS, 1987, 15 (01) :101-111

[5]

BOEHM J J, 1977, Australian Journal of Pharmaceutical Sciences, V6, P107

[6]

Boquet A, 1928, CR HEBD ACAD SCI, V187, P959

[7]

Brockstedt M, 1993, Kinderarztl Prax, V61, P378

[8]

DETOXIFICATION OF PLASMA CONTAINING LIPOPOLYSACCHARIDE BY ADSORPTION [J].

BYSANI, GK ;

SHENEP, JL ;

HILDNER, WK ;

STIDHAM, GL ;

ROBERSON, PK .

CRITICAL CARE MEDICINE, 1990, 18 (01) :67-71

[9]

PROTEIN-POLYMER INTERACTION - CHANGES WITH PLASMA COMPONENTS, VITAMINS, AND ANTIPLATELET DRUGS AT THE INTERFACE [J].

CHANDY, T ;

SHARMA, CP .

POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING, 1987, 26 (3-4) :143-227

[10]

BIODEGRADABLE CHITOSAN MATRIX FOR THE CONTROLLED RELEASE OF STEROIDS [J].

CHANDY, T ;

SHARMA, CP .

BIOMATERIALS ARTIFICIAL CELLS AND IMMOBILIZATION BIOTECHNOLOGY, 1991, 19 (04) :745-760

← 1 2 3 4 5 6 7 8 →